Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIV-711 extension in knee osteoarthritis
NCT03037489Phase 2Completed
- Sponsor
- Medivir
- Start
- Sep 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of MIV-711 in knee osteoarthritis (OA), sponsored by Medivir. Started Sep 2016; status: completed.
02
Drugs
MIV-711
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03037489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03037489.